{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T08:11:31Z","timestamp":1749024691274,"version":"3.40.5"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,7,18]],"date-time":"2023-07-18T00:00:00Z","timestamp":1689638400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,18]],"date-time":"2023-07-18T00:00:00Z","timestamp":1689638400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1007\/s00520-023-07951-9","type":"journal-article","created":{"date-parts":[[2023,7,18]],"date-time":"2023-07-18T05:01:43Z","timestamp":1689656503000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Clinical features and outcomes of patients admitted to the ICU for Cyclophosphamide-associated cardiac toxicity: a retrospective cohort"],"prefix":"10.1007","volume":"31","author":[{"given":"Alice","family":"Vennier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2143-8082","authenticated-orcid":false,"given":"Emmanuel","family":"Canet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vianney","family":"Guardiolle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florian","family":"Reizine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-No\u00ebl","family":"Trochu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thierry","family":"Le Tourneau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cyrille","family":"Touzeau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roch","family":"Houot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Am\u00e9lie","family":"Seguin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean","family":"Reignier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Baptiste","family":"Lascarrou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Marc","family":"Tadi\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4121-9186","authenticated-orcid":false,"given":"J\u00e9r\u00e9mie","family":"Emari\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,7,18]]},"reference":[{"key":"7951_CR1","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1056\/NEJMp1113569","volume":"366","author":"DS Jones","year":"2012","unstructured":"Jones DS, Podolsky SH, Greene JA (2012) The Burden of Disease and the Changing Task of Medicine. N Engl J Med 366:2333\u20132338. https:\/\/doi.org\/10.1056\/NEJMp1113569","journal-title":"N Engl J Med"},{"key":"7951_CR2","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1002\/ijc.25516","volume":"127","author":"J Ferlay","year":"2010","unstructured":"Ferlay J, Shin H-R, Bray F et al (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. International Journal of Cancer 127:2893\u20132917. https:\/\/doi.org\/10.1002\/ijc.25516","journal-title":"International Journal of Cancer"},{"key":"7951_CR3","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1200\/JCO.2015.65.8427","volume":"34","author":"DS Dizon","year":"2016","unstructured":"Dizon DS, Krilov L, Cohen E et al (2016) Clinical Cancer Advances 2016: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology. J Clin Oncol 34:987\u20131011. https:\/\/doi.org\/10.1200\/JCO.2015.65.8427","journal-title":"J Clin Oncol"},{"key":"7951_CR4","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1016\/S0140-6736(11)61040-4","volume":"378","author":"C R\u00e9cher","year":"2011","unstructured":"R\u00e9cher C, Coiffier B, Haioun C et al (2011) Intensified chemotherapy with ACVBP plus rituximab versus standard CHOP plus rituximab for the treatment of diffuse large B-cell lymphoma (LNH03-2B): an open-label randomised phase 3 trial. Lancet 378:1858\u20131867. https:\/\/doi.org\/10.1016\/S0140-6736(11)61040-4","journal-title":"Lancet"},{"key":"7951_CR5","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1016\/j.ejca.2015.07.025","volume":"51","author":"P Baili","year":"2015","unstructured":"Baili P, Di Salvo F, Marcos-Gragera R et al (2015) Age and case mix-standardised survival for all cancer patients in Europe 1999\u20132007: Results of EUROCARE-5, a population-based study. Eur J Cancer 51:2120\u20132129. https:\/\/doi.org\/10.1016\/j.ejca.2015.07.025","journal-title":"Eur J Cancer"},{"key":"7951_CR6","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1007\/s00134-020-06184-2","volume":"47","author":"FG Zampieri","year":"2021","unstructured":"Zampieri FG, Romano TG, Salluh JIF et al (2021) Trends in clinical profiles, organ support use and outcomes of patients with cancer requiring unplanned ICU admission: a multicenter cohort study. Intensive Care Med 47:170\u2013179. https:\/\/doi.org\/10.1007\/s00134-020-06184-2","journal-title":"Intensive Care Med"},{"key":"7951_CR7","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1007\/s00134-021-06502-2","volume":"47","author":"BL Ferreyro","year":"2021","unstructured":"Ferreyro BL, Scales DC, Wunsch H et al (2021) Critical illness in patients with hematologic malignancy: a population-based cohort study. Intensive Care Med 47:1104\u20131114. https:\/\/doi.org\/10.1007\/s00134-021-06502-2","journal-title":"Intensive Care Med"},{"key":"7951_CR8","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1093\/eurheartj\/ehw211","volume":"37","author":"JL Zamorano","year":"2016","unstructured":"Zamorano JL, Lancellotti P, Rodriguez Mu\u00f1oz D et al (2016) 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC). Eur Heart J 37:2768\u20132801. https:\/\/doi.org\/10.1093\/eurheartj\/ehw211","journal-title":"Eur Heart J"},{"key":"7951_CR9","first-page":"559","volume":"4","author":"GW Santos","year":"1972","unstructured":"Santos GW, Sensenbrenner LL, Burke PJ et al (1972) The use of cyclophosphamide for clinical marrow transplantation. Transplant Proc 4:559\u2013564","journal-title":"Transplant Proc"},{"key":"7951_CR10","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1186\/s13104-017-2726-2","volume":"10","author":"K Kurauchi","year":"2017","unstructured":"Kurauchi K, Nishikawa T, Miyahara E et al (2017) Role of metabolites of cyclophosphamide in cardiotoxicity. BMC Res Notes 10:406. https:\/\/doi.org\/10.1186\/s13104-017-2726-2","journal-title":"BMC Res Notes"},{"key":"7951_CR11","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1093\/toxsci\/kfu233","volume":"143","author":"A Moghe","year":"2015","unstructured":"Moghe A, Ghare S, Lamoreau B et al (2015) Molecular Mechanisms of Acrolein Toxicity: Relevance to Human Disease. Toxicol Sci 143:242\u2013255. https:\/\/doi.org\/10.1093\/toxsci\/kfu233","journal-title":"Toxicol Sci"},{"key":"7951_CR12","doi-asserted-by":"publisher","first-page":"e0131394","DOI":"10.1371\/journal.pone.0131394","volume":"10","author":"T Nishikawa","year":"2015","unstructured":"Nishikawa T, Miyahara E, Kurauchi K et al (2015) Mechanisms of Fatal Cardiotoxicity following High-Dose Cyclophosphamide Therapy and a Method for Its Prevention. PLoS One 10:e0131394. https:\/\/doi.org\/10.1371\/journal.pone.0131394","journal-title":"PLoS One"},{"key":"7951_CR13","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1001\/archinte.1981.00340060066015","volume":"141","author":"JS Gottdiener","year":"1981","unstructured":"Gottdiener JS, Appelbaum FR, Ferrans VJ et al (1981) Cardiotoxicity associated with high-dose cyclophosphamide therapy. Arch Intern Med 141:758\u2013763","journal-title":"Arch Intern Med"},{"key":"7951_CR14","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1182\/blood.V68.5.1114.1114","volume":"68","author":"MA Goldberg","year":"1986","unstructured":"Goldberg MA, Antin JH, Guinan EC, Rappeport JM (1986) Cyclophosphamide cardiotoxicity: an analysis of dosing as a risk factor. Blood 68:1114\u20131118","journal-title":"Blood"},{"key":"7951_CR15","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.jjcc.2009.01.006","volume":"54","author":"M Katayama","year":"2009","unstructured":"Katayama M, Imai Y, Hashimoto H et al (2009) Fulminant fatal cardiotoxicity following cyclophosphamide therapy. J Cardiol 54:330\u2013334. https:\/\/doi.org\/10.1016\/j.jjcc.2009.01.006","journal-title":"J Cardiol"},{"key":"7951_CR16","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1002\/1097-0142(19860515)57:10<2061::AID-CNCR2820571031>3.0.CO;2-H","volume":"57","author":"B Cazin","year":"1986","unstructured":"Cazin B, Gorin NC, Laporte JP et al (1986) Cardiac complications after bone marrow transplantation. A report on a series of 63 consecutive transplantations. Cancer 57:2061\u20132069. https:\/\/doi.org\/10.1002\/1097-0142(19860515)57:10<2061::AID-CNCR2820571031>3.0.CO;2-H","journal-title":"Cancer"},{"key":"7951_CR17","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.jaccao.2021.02.011","volume":"3","author":"R Dul\u00e9ry","year":"2021","unstructured":"Dul\u00e9ry R, Mohty R, Labopin M et al (2021) Early Cardiac Toxicity Associated With Post-Transplant Cyclophosphamide in Allogeneic Stem Cell Transplantation. JACC: CardioOncology 3:250\u2013259. https:\/\/doi.org\/10.1016\/j.jaccao.2021.02.011","journal-title":"JACC: CardioOncology"},{"key":"7951_CR18","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1007\/s00277-016-2654-6","volume":"95","author":"S Ishida","year":"2016","unstructured":"Ishida S, Doki N, Shingai N et al (2016) The clinical features of fatal cyclophosphamide-induced cardiotoxicity in a conditioning regimen for allogeneic hematopoietic stem cell transplantation (allo-HSCT). Ann Hematol 95:1145\u20131150. https:\/\/doi.org\/10.1007\/s00277-016-2654-6","journal-title":"Ann Hematol"},{"key":"7951_CR19","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/s0140-6736(76)90151-3","volume":"1","author":"F Appelbaum","year":"1976","unstructured":"Appelbaum F, Strauchen JA, Graw RG et al (1976) Acute lethal carditis caused by high-dose combination chemotherapy. A unique clinical and pathological entity. Lancet 1:58\u201362. https:\/\/doi.org\/10.1016\/s0140-6736(76)90151-3","journal-title":"Lancet"},{"key":"7951_CR20","doi-asserted-by":"publisher","first-page":"263","DOI":"10.2165\/00002018-200022040-00002","volume":"22","author":"VB Pai","year":"2000","unstructured":"Pai VB, Nahata MC (2000) Cardiotoxicity of Chemotherapeutic Agents: Incidence, Treatment and Prevention. Drug Safety 22:263\u2013302. https:\/\/doi.org\/10.2165\/00002018-200022040-00002","journal-title":"Drug Safety"},{"key":"7951_CR21","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1016\/j.jacc.2009.02.050","volume":"53","author":"ETH Yeh","year":"2009","unstructured":"Yeh ETH, Bickford CL (2009) Cardiovascular Complications of Cancer Therapy. J Am Coll Cardiol 53:2231\u20132247. https:\/\/doi.org\/10.1016\/j.jacc.2009.02.050","journal-title":"J Am Coll Cardiol"},{"key":"7951_CR22","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1002\/1097-0142(197906)43:6<2223::AID-CNCR2820430610>3.0.CO;2-Y","volume":"43","author":"BA Mills","year":"1979","unstructured":"Mills BA, Roberts RW (1979) Cyclophosphamide-induced cardiomyopathy. A report of two cases and review of the english literature. Cancer 43:2223\u20132226. https:\/\/doi.org\/10.1002\/1097-0142(197906)43:6<2223::AID-CNCR2820430610>3.0.CO;2-Y","journal-title":"Cancer"},{"key":"7951_CR23","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.bbmt.2008.03.005","volume":"14","author":"L Luznik","year":"2008","unstructured":"Luznik L, O\u2019Donnell PV, Symons HJ et al (2008) HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide. Biol Blood Marrow Transplant 14:641\u2013650. https:\/\/doi.org\/10.1016\/j.bbmt.2008.03.005","journal-title":"Biol Blood Marrow Transplant"},{"key":"7951_CR24","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jaccao.2019.09.007","volume":"1","author":"JAM Kamphuis","year":"2019","unstructured":"Kamphuis JAM, Linschoten M, Cramer MJ et al (2019) Cancer Therapy-Related Cardiac Dysfunction of Nonanthracycline Chemotherapeutics. JACC: CardioOncology 1:280\u2013290. https:\/\/doi.org\/10.1016\/j.jaccao.2019.09.007","journal-title":"JACC: CardioOncology"},{"key":"7951_CR25","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/sj.bmt.1704763","volume":"35","author":"P Morandi","year":"2005","unstructured":"Morandi P, Ruffini PA, Benvenuto GM et al (2005) Cardiac toxicity of high-dose chemotherapy. Bone Marrow Transplant 35:323\u2013334. https:\/\/doi.org\/10.1038\/sj.bmt.1704763","journal-title":"Bone Marrow Transplant"},{"key":"7951_CR26","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.hrtlng.2022.12.003","volume":"58","author":"C Blazoski","year":"2023","unstructured":"Blazoski C, Kirupaharan P, Hilton R et al (2023) Outcomes of extracorporeal membrane oxygenation in immunosuppressed vs Immunocompetent patients. Heart Lung 58:179\u2013184. https:\/\/doi.org\/10.1016\/j.hrtlng.2022.12.003","journal-title":"Heart Lung"},{"key":"7951_CR27","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1164\/rccm.201708-1761OC","volume":"197","author":"M Schmidt","year":"2018","unstructured":"Schmidt M, Schellongowski P, Patroniti N et al (2018) Six-Month Outcome of Immunocompromised Patients with Severe Acute Respiratory Distress Syndrome Rescued by Extracorporeal Membrane Oxygenation. An International Multicenter Retrospective Study. Am J Respir Crit Care Med 197:1297\u20131307. https:\/\/doi.org\/10.1164\/rccm.201708-1761OC","journal-title":"Am J Respir Crit Care Med"},{"key":"7951_CR28","doi-asserted-by":"publisher","first-page":"R20","DOI":"10.1186\/cc13701","volume":"18","author":"P Wohlfarth","year":"2014","unstructured":"Wohlfarth P, Ullrich R, Staudinger T et al (2014) Extracorporeal membrane oxygenation in adult patients with hematologic malignancies and severe acute respiratory failure. Crit Care 18:R20. https:\/\/doi.org\/10.1186\/cc13701","journal-title":"Crit Care"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-023-07951-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-023-07951-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-023-07951-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T08:09:56Z","timestamp":1691741396000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-023-07951-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,18]]},"references-count":28,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["7951"],"URL":"https:\/\/doi.org\/10.1007\/s00520-023-07951-9","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"type":"print","value":"0941-4355"},{"type":"electronic","value":"1433-7339"}],"subject":[],"published":{"date-parts":[[2023,7,18]]},"assertion":[{"value":"25 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the ethics committee of the French Intensive Care Society (CE SRLF 22-058) on December 18, 2022.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"In accordance with French law on retrospective studies of anonymized healthcare data, informed consent was not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"EC has received lecturer and conference-speaker fees, as well as reimbursements of travel and accommodation expenses related to attending scientific meetings, from Gilead, Shionogi, and Sanofi-Genzyme. JBL has received lecturer and conference-speaker fees from BD and Zoll. RH reports honoraria from Kite\/Gilead, Novartis, Incyte, Janssen, MSD, Takeda and Roche; and consultancy at Kite\/Gilead, Novartis, Bristol-Myers Squibb\/Celgene, ADC Therapeutics, Incyte, Miltenyi. None of the other authors have relevant financial or non-financial interests to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"474"}}